top of page

Revolutionizing Maternal Health: Early Detection, Better Outcomes

We use Microbiome and ML to identify expecting moms at high-risk of pregnancy complications.

For payers, providers, and plans 

About Us

MaMome is currently studying how your microbiome can be used to predict and prevent the later development of certain disease conditions, specifically during pregnancy. Our platform leverages precise microbiome sequencing technology for accurate and cost-effective sample testing. 

Clinical Trials registration number 



MaMome is at the forefront of innovation in the field of pregnancy care with its proprietary testing and bioinformatic pipeline platform, which is poised to revolutionize the way we approach early diagnostics and management of pregnancy complications using microbiome-based techniques.

Interested in partnering? Contact us at

Established Partnerships:


Complications like preeclampsia, gestational diabetes, and preterm birth cause long-term health effects for both mother and baby and increase your risk for birth interventions. Accurately identifying women at higher risk for pregnancy complications is the first step to preventing pregnancy complications. 


Help us unlock the maternal microbiome by participating in one of our research studies. We provide all participants with no-cost wellness coaching to assist with a healthy diet and other healthy pregnancy behaviors. Studies are completely non-invasive, and you can participate from your own home.

Nini Fan, MBA, MS

Co-founder &

Chief Executive Officer 

Norihiro Yogo, MD

Co-founder &

Chief Operation Officer

Stephanie McClellan, MD

Co-founder &

Chief Medical Officer



MaMome Inc.
1 University Plaza
Brooklyn, NY 11201


bottom of page